Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Century Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
Revenues5.20.00.0
Cost of goods sold0.00.00.0
Gross profit5.20.00.0
            Gross margin100.0%  
Research and development97.275.639.7
General and administrative31.919.29.5
EBIT-123.8-94.9-53.9
            EBIT margin-2381.8%  
Pre-tax income-130.8-95.8-53.6
Income taxes0.10.00.0
            Tax rate  0.0%
Net income-130.9-95.8-53.6
            Net margin-2518.4%  
 
Diluted EPS($2.27)($2.96)($7.16)
Shares outstanding (diluted)57.832.47.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy